Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mas-related G protein-coupled receptor member D (MRGPRD) is a member of the MAS-related GPCR family highly expressed in sensory neurons (particularly dorsal root ganglion), cardiovascular tissue, mast cells, macrophages, and certain tumors. This receptor mediates pain and itch signals, inflammatory cytokine release (notably IL-6), and is activated by β-alanine, alamandine, angiotensin II, and 5-oxoeicosatetraenoic acid. Structurally, MrgD features a shallow ligand-binding pocket and unique disulfide bonding characteristics, distinguishing its activation mode from classic class A GPCRs. Pathophysiologically, MRGPRD is implicated in neuropathic pain, cold allodynia, cardiovascular function, pseudorelergic reactions, certain cancers, and osteocyte survival. Its high basal activity and ligand promiscuity pose challenges for drug development and in vitro screening, but also point to its role in constitutive cellular signaling and modulation.
Agonists like β-alanine activate the MRGPRD, triggering Gq-mediated phospholipase C (PLC) pathway, leading to IP3/DAG formation and release of inflammatory mediators (e.g., IL-6). Also couples to Gi, modulating cAMP and KCNQ channels, increasing neuronal excitability (pain/itch). Activation leads to inactivation of KCNQ channels, increased neuronal excitation, and sensation of pain and itch. Alamandine/Ang(1-7) activation leads to NO release, counteracting cardiovascular fibrosis/hypertension.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mas-related G protein-coupled receptor member D (MRGPRD).